Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Siltanen CA"'
Autor:
Madrigal JL; Scribe Biosciences, San Francisco, CA 94107., Schoepp NG; Scribe Biosciences, San Francisco, CA 94107., Xu L; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158., Powell CS; Scribe Biosciences, San Francisco, CA 94107., Delley CL; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158., Siltanen CA; Scribe Biosciences, San Francisco, CA 94107., Danao J; Chimera Bioengineering, South San Francisco, CA 94080., Srinivasan M; Scribe Biosciences, San Francisco, CA 94107., Cole RH; Scribe Biosciences, San Francisco, CA 94107; russell.cole@scribebiosciences.com arabate@gmail.com., Abate AR; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158; russell.cole@scribebiosciences.com arabate@gmail.com.; Chan Zuckerberg Biohub, San Francisco, CA 94158.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Feb 01; Vol. 119 (5).
Autor:
Zhang JQ; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA., Siltanen CA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; Scribe Biosciences, Inc., San Francisco, CA, USA., Dolatmoradi A; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Sun C; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Chang KC; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Cole RH; Scribe Biosciences, Inc., San Francisco, CA, USA., Gartner ZJ; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Abate AR; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.; Chan Zuckerberg Biohub, San Francisco, CA, USA. adam@abatelab.org.; California Institute for Quantitative Biosciences, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.
Publikováno v:
Scientific reports [Sci Rep] 2021 Feb 23; Vol. 11 (1), pp. 4351. Date of Electronic Publication: 2021 Feb 23.
Autor:
Zhang JQ; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA., Siltanen CA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Liu L; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Chang KC; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Gartner ZJ; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.; California Institute for Quantitative Biosciences, University of California San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Abate AR; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.; California Institute for Quantitative Biosciences, University of California San Francisco, San Francisco, CA, USA. adam@abatelab.org.; Chan Zuckerberg Biohub, San Francisco, CA, USA. adam@abatelab.org.
Publikováno v:
Genome biology [Genome Biol] 2020 Feb 24; Vol. 21 (1), pp. 49. Date of Electronic Publication: 2020 Feb 24.
Autor:
Siltanen CA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA., Cole RH; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA., Poust S; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA., Chao L; Amyris, Inc. Emeryville, California, USA., Tyerman J; Amyris, Inc. Emeryville, California, USA.; Delv Bio, Sacramento, California, USA., Kaufmann-Malaga B; Amyris, Inc. Emeryville, California, USA., Ubersax J; Amyris, Inc. Emeryville, California, USA., Gartner ZJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.; Chan Zuckerberg Biohub, San Francisco, California, USA., Abate AR; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA. arabate@gmail.com.; Chan Zuckerberg Biohub, San Francisco, California, USA. arabate@gmail.com.
Publikováno v:
Scientific reports [Sci Rep] 2018 May 21; Vol. 8 (1), pp. 7913. Date of Electronic Publication: 2018 May 21.
Autor:
Cole RH; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143.; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158., Tang SY; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143., Siltanen CA; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143., Shahi P; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143., Zhang JQ; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143.; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158.; UC Berkeley-UCSF Graduate Program in Bioengineering, University of California, San Francisco, CA 94158., Poust S; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143., Gartner ZJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; arabate@gmail.com zev.gartner@ucsf.edu.; Chan Zuckerberg Biohub, San Francisco, CA 94158., Abate AR; Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158; arabate@gmail.com zev.gartner@ucsf.edu.; Chan Zuckerberg Biohub, San Francisco, CA 94158.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2017 Aug 15; Vol. 114 (33), pp. 8728-8733. Date of Electronic Publication: 2017 Jul 31.